Indian drug protectionism wins again
On Monday, the Indian Supreme Court ended a seven year legal fight with drug company Novartis when it denied a patent for the company’s blockbuster Leukemia drug, Glivec. Health activists hailed the decision as a godsend that will ensure India … read more









